| AFP | Acute flaccid paralysis |
bOPV | Bivalent oral polio vaccine (containing attenuated Sabin poliovirus type 1 and type 3) |
| CAG | Containment Advisory Group |
CC | Certificate of containment |
| CCID | Cell culture infectious dose |
CCID50 | Cell culture infectious dose, 50% endpoint |
| CCS GAPIII | Containment Certification Scheme |
cDNA | Complementary DNA |
| CP | Certificate of participation (in the containment certification process) |
CSF | Cerebrospinal fluid |
| cVDPV | Circulating vaccine-derived poliovirus |
cVDPV1 | Circulating vaccine-derived poliovirus type 1 |
| cVDPV2 | Circulating vaccine-derived poliovirus type 2 |
cVDPV3 | Circulating vaccine-derived poliovirus type 3 |
| CWG | Certification Working Group |
| |